You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Related products

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-Cdc25A (phospho S17) antibody (ab18321)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-Cdc25A (phospho S17) antibody
See all Cdc25A products (18) ...

Description

Rabbit polyclonal to Cdc25A (phospho S17)

Tested applications

WB, IHC-Pmore details

Cross reactivity

Reacts with

Human

Immunogen

Synthetic peptide (Human).

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

Storage buffer

Preservative: 0.09% Sodium Azide
Constituents: 50% Glycerol, PBS, pH 7.2

Concentration

Concentration information loading...

Purity

Immunogen affinity purified

Clonality

Polyclonal

Isotype

IgG

  • Western blot - Cdc25A (phospho S17) antibody (ab18321)Western blot - Cdc25A (phospho S17) antibody (ab18321) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab18321 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Target

Function

Tyrosine protein phosphatase which functions as a dosage-dependent inducer of mitotic progression. Directly dephosphorylates CDK1 and stimulates its kinase activity. Also dephosphorylates CDK2 in complex with cyclin E, in vitro.

Sequence similarities

Belongs to the MPI phosphatase family.
Contains 1 rhodanese domain.

Domain

The phosphodegron motif mediates interaction with specific F-box proteins when phosphorylated. Putative phosphorylation sites at Ser-79 and Ser-82 appear to be essential for this interaction.

Post-translational
modifications

Phosphorylated by CHEK1 on Ser-76, Ser-124, Ser-178, Ser-279, Ser-293 and Thr-507 during checkpoint mediated cell cycle arrest. Also phosphorylated by CHEK2 on Ser-124, Ser-279, and Ser-293 during checkpoint mediated cell cycle arrest. Phosphorylation on Ser-178 and Thr-507 creates binding sites for YWHAE/14-3-3 epsilon which inhibits CDC25A. Phosphorylation on Ser-76, Ser-124, Ser-178, Ser-279 and Ser-293 may also promote ubiquitin-dependent proteolysis of CDC25A by the SCF complex.
Ubiquitinated by the anaphase promoting complex/cyclosome (APC/C) ubiquitin ligase complex that contains FZR1/CDH1 during G1 phase leading to its degradation by the proteasome. Ubiquitinated by a SCF complex containing BTRC and FBXW11 during S phase leading to its degradation by the proteasome. Deubiquitination by USP17L2/DUB3 leads to its stabilization.

Target information above from: UniProt accessionP30304 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • Cdc 25a antibody
  • CDC25A antibody
  • CDC25A2 antibody
  • CDC25A2 CAG isoform antibody
  • Cell division cycle 25 homolog A (S. pombe) antibody
  • Cell division cycle 25A antibody
  • Cell division cycle 25A isoform a antibody
  • Cell division cycle 25A isoform b antibody
  • D9Ertd393e antibody
  • Dual specificity phosphatase CDC25A antibody
  • EC 3.1.3.48 antibody
  • M phase inducer phosphatase 1 antibody
  • M-phase inducer phosphatase 1 antibody
  • MGC115549 antibody
  • MPIP1_HUMAN antibody
see all

Anti-Cdc25A (phospho S17) antibody images:

  Western blot - Cdc25A (phospho S17) antibody (ab18321)

Western blot - Cdc25A (phospho S17) antibody (ab18321)



Predicted band size : 59 kDa


Hela cells were treated with 300 µM mimosine for 16 hrs, then placed in complete media (lane 1) or media containing 200 ng/ml nocodazole (lane 2) for an additional 18hrs. Nuclear extract was prepared, resolved by electrophoresis, transferred to nitrocellulose, and probed with rabbit antibodies reactive against phosphorylated Cdc25A (Ser17). Proteins were visualized using a donkey anti-rabbit secondary conjugated to HRP and a chemiluminescence detection system.

References for Anti-Cdc25A (phospho S17) antibody (ab18321)

This product has been referenced in:

  • Madlener Set al. Multifactorial anticancer effects of digalloyl-resveratrol encompass apoptosis, cell-cycle arrest, and inhibition of lymphendothelial gap formation in vitro. Br J Cancer 102:1361-70 (2010). WB; Human.Read more (PubMed: 20424615) »
  • Vo NTet al. Pro- and anticarcinogenic mechanisms of piceatannol are activated dose dependently in MCF-7 breast cancer cells. Carcinogenesis 31:2074-81 (2010). WB; Human.Read more (PubMed: 19696164) »

See all 4 publications for this product

Publishing research using ab18321? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"